Is the Fed Put Back in Play, and What’s Next for Biogen? 9/28/22
Stocks rallying after hitting the year’s lows as one central bank indicated it’s willing to step in to calm the markets. But will the Fed follow suit or is there more turmoil ahead? Plus Biogen making a major breakthrough with its Alzheimer’s treatment. What it means for the stock and the rest of the biotech space.…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Similar episodes from other shows
More like CNBC's "Fast Money" →
CNBC Special Report: The Fed Factor 9/26/22
9-14-2022 – Stocks Stabilized Following Their Massive Sell-Off
Helene Meisler On What's Going On With the Stock Market Now
What the Stock Market Panic Says About the Economy
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.